Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy(The University of Texas MD Anderson Cancer Center), Seock‐Ah Im(Seoul National University Hospital), Marco Colleoni(European Institute of Oncology), Fábio Franke(Hospital Universitário Cajuru), Aditya Bardia(Harvard University), Nadia Harbeck, Sara A. Hurvitz(UCLA Jonsson Comprehensive Cancer Center), Louis W.C. Chow(Unimed Medical Institute), Joohyuk Sohn(Yonsei University Health System), Keun Seok Lee(National Cancer Center), Saúl Campos-Gómez(Instituto de Salud del Estado de México), Rafael Villanueva-Vázquez(Institut Català d'Oncologia), Kyung Hae Jung(Ulsan College), Govind Babu(Kidwai Memorial Institute of Oncology), Paul Wheatley‐Price(University of Ottawa), Michelino De Laurentiis(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Young‐Hyuck Im(Samsung Medical Center), Sherko Küemmel(Kliniken Essen-Mitte), Nagi S. El-Saghir(American University of Beirut Medical Center), Mei-Ching Liu(Koo Foundation Sun Yat-Sen Cancer Center), Gary P. Carlson(Novartis (United States)), Gareth Hughes(Novartis (Switzerland)), Iván Díaz-Padilla(Novartis (Switzerland)), Caroline Germa(Novartis (United States)), Samit Hirawat(Novartis (United States)), Yen‐Shen Lu(National Taiwan University Hospital)
Cited by 1,005
Abstract
Related Papers
No related papers found
Powered by citation graph analysis